Paratek Pharmaceuticals
PRTK
#9014
Rank
C$0.17 B
Marketcap
C$3.08
Share price
0.00%
Change (1 day)
12.83%
Change (1 year)

Earnings for Paratek Pharmaceuticals (PRTK)

Earnings in 2023 (TTM): -C$59.28 Million

According to Paratek Pharmaceuticals 's latest financial reports the company's current earnings are C$0.16 Billion. In 2022 the company made an earning of -C$62.71 Million a decrease over its 2021 earnings that were of -C$56.75 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Paratek Pharmaceuticals from 2004 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -C$59.28 Million-5.47%
2022 -C$62.71 Million10.5%
2021 -C$56.75 Million-46.16%
2020 -C$0.11 Billion-31.93%
2019 -C$0.16 Billion11.12%
2018 -C$0.14 Billion21.19%
2017 -C$0.12 Billion-23.22%
2016 -C$0.15 Billion54.68%
2015 -C$96.83 Million309.5%
2014 -C$23.65 Million-29.88%
2013 -C$33.73 Million
2011 -C$5.2 Million-59.18%
2010 -C$12.75 Million-53.53%
2009 -C$27.42 Million-161.93%
2008 C$44.27 M-187.43%
2007 -C$50.64 Million11.93%
2006 -C$45.24 Million31.69%
2005 -C$34.35 Million32.4%
2004 -C$25.95 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Spectrum Pharmaceuticals
SPPI
-C$85.49 Million 41.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
C$28.54 M-147.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-C$0.72 Billion 1,086.69%๐Ÿ‡บ๐Ÿ‡ธ USA